CN

ABOUT US

WESTCHINA-FRONTIER PHARMATECH

WestChina-Frontier PharmaTech Co., Ltd.

Founded in 2000, WestChina-Frontier Pharmatech is a professional GLP facility.

After more than 20 years of development, WCFP has established a standardized, international, large scale, information-based non-clinical drug research and evaluation center, becoming an important technical support system for new drug development and an innovation center for new drug evaluation technology in China.

Backed by the outstanding scientific research and clinical resources of West China Hospital of Sichuan University, WCFP has achieved in-depth integration of industry-academia-research resources and technical innovation.

WCFP has successively passed NMPA GLP certification, U.S. FDA GLP on-site inspection, OECD GLP certification, AAALAC International certification, U.S. CAP certification and CNAS certification many times. We have taken the lead in the construction of LIMS system in line with international standards, realizing the international standardization of data management technology.

Covering an area of over 100 acres, WCFP has GLP-compliant advanced experimental facilities of about 80,000 square meters, a professional team of more than a thousand technical talents along with state-of-the-art testing and analytical equipment for experimental researches in rats, mice, Guinea pigs, rabbits, dog, miniature pigs, monkeys, and other laboratory animals. WCFP offers a wide variety of services, covering non-clinical efficacy and safety study and assessment of chemical drugs, biotech drugs, vaccines, traditional Chinese medicines, cell products, and gene therapy products, development of analytical methods for small molecules and biomolecules, and immunogenicity studies.

Using the FDA-approved data acquisition system (Pristima®), WCFP can provide clients with multilateral regulatory submission services in China, the United States, EU, Japan and Korea. So far, it has completed the non-clinical research and evaluation of more than a thousand new drugs and successfully submitted regulatory application dossiers to FDA for more than a hundred new drugs.

Adhering to high-quality and standardized quality services, WCFP has established long-term partnerships with Chinese and foreign pharmaceutical companies and research institutions and has built a good international brand reputation.

  • 2000

    EST.

  • 1300+

    Technical Team of

  • 80000+

    Total Facility Size of

  • 1000+

    Drug Evaluation of

Adhering to high-quality and standardized quality services, WCFP has established long-term partnerships with Chinese and foreign pharmaceutical companies and research institutions and has built a good international brand reputation.

SupportNew Drug Creation

Serve Global New Drug Safety Assessment

Adhering to high-quality and standardized quality services, WCFP has established long-term partnerships with Chinese and foreign pharmaceutical companies and research institutions and has built a good international brand reputation.

SupportNew Drug Creation

Serve Global New Drug Safety Assessment

Swipe the mouse left and right to switch

Development milestones

2022

WCFP Tianfu Drug Research Center
Obtained NMPA GLP Certification Since 2022

2020

WCFP Tianfu Drug Research Center Operated
CNAS Accredited Since 2020

2018

Established Standard for Exchange of Nonclinical Data Format

2017

FDA GLP On-Site Inspection Since 2017

2014

OECD GLP & CAP Accreditation Since 2014

2009

Phase II of WCFP (National Chengdu Center for Safety Evaluation of drugs) Operated.

2007

AAALAC International Accreditation Since 2007

2004

1st CFDA (NMPA) GLP Accreditation
One of the Five GLP-Compliant Facilities in China

2000

WestChina-Frontier PharmaTech Co., Ltd. was Founded

2022
2020
2018
2017
2014
2009
2007
2004
2000

Awards & Recognition

NMPA GLP certification

AAALAC International certification

U.S. CAP certification

Animal welfare

As an AAALAC International accredited facility, we are committed to maintaining high standards of animal welfare. According to Chinas' Regulations for the Administration of Laboratory Animals and U.S. Guide for the Care and Use of Laboratory Animals, WestChina-Frontier’s Institutional Animal Care and Use Committee (IACUC) is responsible for supervising animal use and husbandry, conducting regular inspections, standardizing procedures and implementing training, so as to ensure professional standards and the highest level of animal welfare.

Responsibilities of IACUC

· Review of study protocols

· Inspection of laboratory facilities

· Animal welfare and occupational safety related training

· Management of occupational safety

Management of animal facilities and husbandry

. Daily monitoring of environment temperature, humidity, pressure gradient, noise level, and illumination intensity of laboratory facilities

· Microbiology testing of facility environment and sentinel animals

· Periodical testing of feed, bedding and test environment of laboratory animals by a third-party monitoring facility

· Periodical on-site inspection and evaluation of suppliers of laboratory animals and animal feed

· Establishment of acclimation observations, physiological and biochemical indexes, and relevant databases for laboratory animals

· Establishment of a variety of animal welfare measures, including the provision of toys, paired husbandry, and indoor sports of animals (e.g., dogs).

  • Business Contacts:028-60662528

    E-mail:service@glpcd.com

    +8628-60662518-8800

    +8628-85154334-800

online message×